findmyKOL
Clinical trialNCT00038272CompletedPhase 2Interventional

A Study of DAPD Alone Versus DAPD Plus MMF for Treatment of HIV Infection

SponsorNational Institute of Allergy and Infectious Diseases (NIAID)Enrollment56HIV Infections
View the registry record on ClinicalTrials.gov

Summary

The lay summary the sponsor registered on ClinicalTrials.gov.

The purpose of this study is to evaluate the safety, efficacy, and side effects of beta-D-2,6-diaminopurine dioxolane (DAPD) compared to DAPD plus mycophenolate mofetil (MMF) when these drugs are added to the anti-HIV treatment regimens of people infected with HIV. Some studies have shown that DAPD and MMF can help fight HIV. However, neither DAPD nor MMF has been approved by the Food and Drug Administration for treating HIV infection. This study will help doctors decide if DAPD and MMF are good drugs for treating HIV.
clinicaltrials.gov ↗

Investigators

The overall officials registered on this study. Names that resolve to a findmyKOL profile link to it; the rest are shown as registered.

A profile link is shown only when the registered name resolves to a person record with a confident, namesake-checked match; ambiguous names stay unlinked.

Sites

17 registered facilities, with the per-site recruitment status where the registry publishes one. ClinicalTrials.gov does not publish per-site enrollment counts.

United States
  • Ucla Care Center Crs

    Los Angeles, California, United States

  • Stanford Crs

    Palo Alto, California, United States

  • Uc Davis Medical Center

    Sacramento, California, United States

  • Univ. of California Davis Med. Ctr., Actu

    Sacramento, California, United States

  • University of Colorado Hospital Crs

    Aurora, Colorado, United States

  • Univ. of Miami Aids Crs

    Miami, Florida, United States

  • Univ. of Hawaii at Manoa, Leahi Hosp.

    Honolulu, Hawaii, United States

  • Johns Hopkins Adult Aids Crs

    Baltimore, Maryland, United States

  • University of Minnesota, Actu

    Minneapolis, Minnesota, United States

  • Washington U Crs

    St Louis, Missouri, United States

  • Beth Israel Med. Ctr., Actu

    New York, New York, United States

  • Ny Univ. Hiv/aids Crs

    New York, New York, United States

  • Case Crs

    Cleveland, Ohio, United States

  • Hosp. of the Univ. of Pennsylvania Crs

    Philadelphia, Pennsylvania, United States

  • Univ. of Pennsylvania Health System, Presbyterian Med. Ctr.

    Philadelphia, Pennsylvania, United States

  • Pitt Crs

    Pittsburgh, Pennsylvania, United States

  • University of Washington Aids Crs

    Seattle, Washington, United States

Site investigator names are published by ClinicalTrials.gov only while a study recruits, so completed studies list sites without them.

Drugs studied

The drug and biological interventions registered on this study, normalized to their RxNorm ingredient where possible.

AmdoxovirMycophenolate mofetil →
Linked drugs open the directory filtered to KOLs working with them.clinicaltrials.gov ↗

Registration & key dates

Registry attributes as recorded on the ClinicalTrials.gov study record.

Start
—
Primary completion
—
Completion
30 Apr 2006
Last update posted
1 Nov 2021
Registered enrollment
56
Registry id
NCT00038272
clinicaltrials.gov ↗

Source: ClinicalTrials.gov, via the CTTI AACT database, data as of 24 Aug 2026. Registry facts are shown as registered by the study sponsor; findmyKOL does not interpret them.